TD Asset Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Hold |
160,652
| – | – | ﹤0.01% | 1184 |
|
|
2025
Q1 | $123K | Hold |
160,652
| – | – | ﹤0.01% | 1203 |
|
|
2024
Q4 | $205K | Hold |
160,652
| – | – | ﹤0.01% | 1228 |
|
|
2024
Q3 | $341K | Hold |
160,652
| – | – | ﹤0.01% | 1334 |
|
|
2024
Q2 | $612K | Hold |
160,652
| – | – | ﹤0.01% | 1244 |
|
|
2024
Q1 | $761K | Hold |
160,652
| – | – | ﹤0.01% | 1226 |
|
|
2023
Q4 | $686K | Hold |
160,652
| – | – | ﹤0.01% | 1254 |
|
|
2023
Q3 | $496K | Buy |
160,652
+80,326
| +100% | +$248K | ﹤0.01% | 1284 |
|
|
2023
Q2 | $361K | Buy |
80,326
+51,886
| +182% | +$233K | ﹤0.01% | 1310 |
|
|
2023
Q1 | $162K | Hold |
28,440
| – | – | ﹤0.01% | 1388 |
|
|
2022
Q4 | $172K | Hold |
28,440
| – | – | ﹤0.01% | 1396 |
|
|
2022
Q3 | $185K | Hold |
28,440
| – | – | ﹤0.01% | 1407 |
|
|
2022
Q2 | $148K | Hold |
28,440
| – | – | ﹤0.01% | 1399 |
|
|
2022
Q1 | $196K | Hold |
28,440
| – | – | ﹤0.01% | 1431 |
|
|
2021
Q4 | $354K | Hold |
28,440
| – | – | ﹤0.01% | 1416 |
|
|
2021
Q3 | $889K | Hold |
28,440
| – | – | ﹤0.01% | 1280 |
|
|
2021
Q2 | $911K | Hold |
28,440
| – | – | ﹤0.01% | 1282 |
|
|
2021
Q1 | $1.23M | Buy |
28,440
+5,931
| +26% | +$257K | ﹤0.01% | 1225 |
|
|
2020
Q4 | $1.61M | Hold |
22,509
| – | – | ﹤0.01% | 1084 |
|
|
2020
Q3 | $678K | Buy |
+22,509
| New | +$678K | ﹤0.01% | 1172 |
|